Products
No finished drug products containing nifurtimox are on the market in many countries. Lampit is not approved in many countries.
Structure and properties
Nifurtimox (C10H13N3O5S, Mr = 287.3 g/mol) is a nitrofuran derivative.
Effects
Nifurtimox (ATC P01CC01) has antiparasitic properties. The effects are due to the formation of free radicals.
Indications
- For the treatment of Chagas disease, a parasitic disease also known as South American trypanosomiasis, caused by the protozoan.
- For the treatment of African trypanosomiasis.
Adverse effects
Possible adverse effects include:
- Gastrointestinal discomfort
- Peripheral neuropathy
- Central disorders
- Skin rashes